{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:26:23Z","timestamp":1783110383371,"version":"3.54.6"},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Limited efficacy of glioblastoma treatment with temozolomide (TMZ) due to resistance has prompted researchers to look for adjuvants capable of enhancing TMZ-associated cytotoxicity. The aim of our\n                    <jats:italic>in vitro<\/jats:italic>\n                    study was to evaluate such effects of erucic acid when combined with TMZ in human U87 MG cells. Cells were treated for 24 or 72 h with vehicle (control), TMZ (200 ng\/mL), or TMZ plus EA (20, 40, 80, or 160 \u00b5g\/mL). Cell viability was assessed using the MTT assay, membrane integrity with lactate dehydrogenase (LDH) release, and intracellular redox balance by measuring total antioxidant capacity (TAC) and total oxidant status (TOS). The mRNA expression of apoptosis-related genes (\n                    <jats:italic>p53, p21, Bax, Bcl-2, Bcl-xL<\/jats:italic>\n                    , and\n                    <jats:italic>caspase-3<\/jats:italic>\n                    ) was analysed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Compared with the vehicle control, TMZ plus EA reduced cell viability and increased LDH release, with more pronounced effects at higher EA concentrations and at 72 h. These changes were accompanied by lower TAC and higher TOS, indicating a shift toward a pro-oxidant intracellular environment. At the transcriptional level, the combination induced increased pro-apoptotic Bax, caspase-3, p53, and p21 expression and reduced Bcl-2 and Bcl-xL expression. In conclusion, EA potentiated TMZ-associated cytotoxic responses in U87 MG cells with accompanying oxidative imbalance and apoptosis-related transcriptional changes.\n                  <\/jats:p>","DOI":"10.2478\/aiht-2026-77-4098","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:04:12Z","timestamp":1783105452000},"page":"123-131","source":"Crossref","is-referenced-by-count":0,"title":["Combined\n                    <i>in vitro<\/i>\n                    effects of temozolomide and erucic acid on U87 MG cell viability, oxidative stress, and expression of genes involved in apoptotic signalling"],"prefix":"10.2478","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6771-6669","authenticated-orcid":false,"given":"\u0130brahim","family":"Gecili","sequence":"first","affiliation":[{"name":"Istanbul Beykent University Faculty of Medicine , Department of Medical Pharmacology , Istanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0131d\u0131ka","family":"Gen\u00e7","sequence":"additional","affiliation":[{"name":"Bilecik \u015eeyh Edebali University Faculty of Medicine , Department of Medical Pharmacology , Bilecik , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Hac\u0131m\u00fcft\u00fco\u011flu","sequence":"additional","affiliation":[{"name":"Atat\u00fcrk University Medical Faculty , Department of Medical Pharmacology , Erzurum , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adem","family":"G\u00fcner","sequence":"additional","affiliation":[{"name":"Sinop University Faculty of Health Sciences , Department of Occupational Health and Safety , Sinop , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmanur","family":"Ni\u011fde","sequence":"additional","affiliation":[{"name":"Bilecik \u015eeyh Edebali University Faculty of Medicine , Department of Medical Pharmacology , Bilecik , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00fcbra","family":"Karabulut","sequence":"additional","affiliation":[{"name":"Bilecik \u015eeyh Edebali University Faculty of Medicine , Department of Medical Pharmacology , Bilecik , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00fcndar Okan","family":"Y\u0131llar","sequence":"additional","affiliation":[{"name":"Istanbul Beykent University Faculty of Medicine , Department of Medical Pharmacology , Istanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Taghizadehehghalehjoughi","sequence":"additional","affiliation":[{"name":"Bilecik \u015eeyh Edebali University Faculty of Medicine , Department of Medical Pharmacology , Bilecik , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelaty Mostafa Abdelaty","family":"Hassibelnaby","sequence":"additional","affiliation":[{"name":"Atat\u00fcrk University Medical Faculty , Department of Medical Pharmacology , Erzurum , Turkey"},{"name":"Cairo University Faculty of Veterinary Medicine , Department of Pharmacology , Giza , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_001","doi-asserted-by":"crossref","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987\u201396. doi: 10.1056\/NEJMoa043330","DOI":"10.1056\/NEJMoa043330"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_002","doi-asserted-by":"crossref","unstructured":"Pu J, Yuan K, Tao J, Qin Y, Li Y, Fu J, Li Z, Zhou H, Tang Z, Li L, Gai X, Qin D. Glioblastoma multiforme: an updated overview of temozolomide resistance mechanisms and strategies to overcome resistance. Discov Oncol 2025;16:731. doi: 10.1007\/s12672-025-02567-3","DOI":"10.1007\/s12672-025-02567-3"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_003","doi-asserted-by":"crossref","unstructured":"Altinoz MA, Bilir A, Elmaci \u0130. Erucic acid, a component of Lorenzo's oil and PPAR-\u03b4 ligand modifies C6 glioma growth and toxicity of doxorubicin. Experimental data and a comprehensive literature analysis. Chem Biol Interact 2018;294:107\u201317. doi: 10.1016\/j.cbi.2018.08.024","DOI":"10.1016\/j.cbi.2018.08.024"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_004","doi-asserted-by":"crossref","unstructured":"Zhen Q, Xu Y, Xu Y, Liu X, Zhang Y, Ye D, Han S, Liu S, Zhang Y. Erucic acid, derived by Lactobacillus crispatus, induces ferroptosis in cervical cancer organoids through the PPAR-\u03b4 signaling pathway. Adv Sci (Weinh) 2025;12:e12599. doi: 10.1002\/advs.202512599","DOI":"10.1002\/advs.202512599"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_005","doi-asserted-by":"crossref","unstructured":"Naz\u0131ro\u011flu A, \u00c7arhan A, Naz\u0131ro\u011flu M. Erucic acid increases the potency of cisplatin-induced colorectal cancer cell death and oxidative stress by upregulating the TRPM2 channel. Cell Biol Int 2024;48:1862\u201376. doi: 10.1002\/cbin.12248","DOI":"10.1002\/cbin.12248"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_006","doi-asserted-by":"crossref","unstructured":"Eh Suk VR, Chung I, Misran M. Mixed oleic acid-erucic acid liposomes as a carrier for Anticancer Drugs. Curr Drug Deliv 2020;17:292\u2013302. doi: 10.2174\/1567201817666200210122933","DOI":"10.2174\/1567201817666200210122933"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_007","doi-asserted-by":"crossref","unstructured":"Guo Z, Bergeron KF, Lingrand M, Mounier C. Unveiling the MUFA-cancer connection: insights from endogenous and exogenous perspectives. Int J Mol Sci 2023;24(12):9921. doi: 10.3390\/ijms24129921","DOI":"10.3390\/ijms24129921"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_008","doi-asserted-by":"crossref","unstructured":"Silva JA, Colquhoun A. Effect of polyunsaturated fatty acids on temozolomide drug-sensitive and drug-resistant glioblastoma cells. Biomedicines 2023;11:779. doi: 10.3390\/biomedicines11030779","DOI":"10.3390\/biomedicines11030779"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_009","doi-asserted-by":"crossref","unstructured":"Zhang J, Stevens MF, Bradshaw TD. Temozolomide: mechanisms of action, repair and resistance. Curr Mol Pharmacol 2012;5:102\u201314. doi: 10.2174\/1874467211205010102","DOI":"10.2174\/1874467211205010102"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_010","doi-asserted-by":"crossref","unstructured":"Roos WP, Batista LF, Naumann SC, Wick W, Weller M, Menck CF, Kaina B. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene 2007;26:186\u201397. doi: 10.1038\/sj.onc.1209785","DOI":"10.1038\/sj.onc.1209785"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_011","doi-asserted-by":"crossref","unstructured":"Sharma B, Gupta P, Biswas L, Verma AK, Pasha AM, Thota P, Medhi B. Neuroprotective potential of erucic acid via inhibition of N2a cell lines and rotenone induced Parkinson's disease rat model. Indian J Pharmacol 2023;55:376\u201384. doi: 10.4103\/ijp.ijp_314_23.","DOI":"10.4103\/ijp.ijp_314_23"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_012","doi-asserted-by":"crossref","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55\u201363. doi: 10.1016\/0022-1759(83)90303-4","DOI":"10.1016\/0022-1759(83)90303-4"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_013","doi-asserted-by":"crossref","unstructured":"Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112\u20139. doi: 10.1016\/j.clinbiochem.2003.10.014","DOI":"10.1016\/j.clinbiochem.2003.10.014"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_014","doi-asserted-by":"crossref","unstructured":"Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103\u201311. doi: 10.1016\/j.clinbiochem.2005.08.008","DOI":"10.1016\/j.clinbiochem.2005.08.008"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_015","doi-asserted-by":"crossref","unstructured":"Fotakis G, Timbrell JA. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 2006;160:171\u20137. doi: 10.1016\/j.toxlet.2005.07.001","DOI":"10.1016\/j.toxlet.2005.07.001"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_016","doi-asserted-by":"crossref","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, Garc\u00eda-S\u00e1ez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, J\u00e4\u00e4ttel\u00e4 M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, L\u00f3pez-Ot\u00edn C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Mu\u00f1oz-Pinedo C, Nagata S, Nu\u00f1ez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 2018;25:486\u2013541. doi: 10.1038\/s41418-017-0012-4","DOI":"10.1038\/s41418-017-0012-4"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_017","doi-asserted-by":"crossref","unstructured":"Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of nonapoptotic cell death pathways. Nat Rev Mol Cell Biol 2014;15:135\u201347. doi: 10.1038\/nrm3737","DOI":"10.1038\/nrm3737"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_018","doi-asserted-by":"crossref","unstructured":"G\u00fcner A, Nalbantsoy A, Sukatar A, Karabay Yava\u015fo\u011flu N\u00dc. Apoptosis-inducing activities of Halopteris scoparia L. Sauvageau (Brown algae) on cancer cells and its biosafety and antioxidant properties. Cytotechnology 2019;71:687\u2013704. doi: 10.1007\/s10616-019-00314-5","DOI":"10.1007\/s10616-019-00314-5"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_019","doi-asserted-by":"crossref","unstructured":"Campos-Sandoval JA, G\u00f3mez-Garc\u00eda MC, Santos-Jim\u00e9nez JL, Mat\u00e9s JM, Alonso FJ, M\u00e1rquez J. Antioxidant responses related to temozolomide resistance in glioblastoma. Neurochem Int 2021;149:105136. doi: 10.1016\/j.neuint.2021.105136","DOI":"10.1016\/j.neuint.2021.105136"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_020","doi-asserted-by":"crossref","unstructured":"Nowacka A, \u015aniegocki M, Zi\u00f3\u0142kowska E. Oxidative stress and antioxidants in glioblastoma: mechanisms of action, therapeutic effects and future directions. Antioxidants 2025;14(9):1121. doi: 10.3390\/antiox14091121","DOI":"10.3390\/antiox14091121"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_021","doi-asserted-by":"crossref","unstructured":"Roos WP, Kaina B. DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett 2013;332:237\u201348. doi: 10.1016\/j.canlet.2012.01.007","DOI":"10.1016\/j.canlet.2012.01.007"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_022","doi-asserted-by":"crossref","unstructured":"Sang DP, Li RJ, Lan Q. Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27. Acta Pharmacol Sin 2014;35:832\u20138. doi: 10.1038\/aps.2014.22","DOI":"10.1038\/aps.2014.22"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_023","doi-asserted-by":"crossref","unstructured":"Bak DH, Kang SH, Choi DR, Gil MN, Yu KS, Jeong JH, Lee NS, Lee JH, Jeong YG, Kim DK, Kim DK, Kim JJ, Han SY. Autophagy enhancement contributes to the synergistic effect of vitamin D in temozolomide-based glioblastoma chemotherapy. Exp Ther Med 2016;11:2153\u201362. doi: 10.3892\/etm.2016.3196","DOI":"10.3892\/etm.2016.3196"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_024","doi-asserted-by":"crossref","unstructured":"Aks\u00fct Y, \u015eengelen A, G\u00fcrsoy DM, \u00d6\u011f\u00fctc\u00fc \u0130, Kuvet \u00d6, Pekmez M. Chrysin sensitizes glioblastoma cells and spheroids to temozolomide treatment by reducing EMT and stemness phenotypes, as well as targeting multidrug resistance proteins. Front Pharmacol 2025;16:1643186. doi: 10.3389\/fphar.2025.1643186","DOI":"10.3389\/fphar.2025.1643186"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_025","doi-asserted-by":"crossref","unstructured":"Bharti V, Watkins R, Kumar A, Shattuck-Brandt RL, Mossing A, Mittra A, Shen C, Tsung A, Davies AE, Hanel W, Reneau JC, Chung C, Sizemore GM, Richmond A, Weiss VL, Vilgelm AE. BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis. Cell Rep 2022;41:111826. doi: 10.1016\/j.celrep.2022.111826","DOI":"10.1016\/j.celrep.2022.111826"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_026","doi-asserted-by":"crossref","unstructured":"Kaina B. Temozolomide, procarbazine and nitrosoureas in the therapy of malignant gliomas: update of mechanisms, drug resistance and therapeutic implications. J Clin Med 2023;12(23):7442. doi: 10.3390\/jcm12237442","DOI":"10.3390\/jcm12237442"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_027","doi-asserted-by":"crossref","unstructured":"Beltzig L, Schwarzenbach C, Leukel P, Frauenknecht KBM, Sommer C, Tancredi A, Hegi ME, Christmann M, Kaina B. Senescence is the main trait induced by temozolomide in glioblastoma cells. Cancers (Basel) 2022;14(9):2233. doi: 10.3390\/cancers14092233","DOI":"10.3390\/cancers14092233"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_028","doi-asserted-by":"crossref","unstructured":"Gorgakilas AG, Martin OA, Bonner WM. p21: a two-faced genome guardian. Trends Mol Med 2017;23:310\u20139. doi: 10.1016\/j.molmed.2017.02.001","DOI":"10.1016\/j.molmed.2017.02.001"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_029","doi-asserted-by":"crossref","unstructured":"Ferreira C, Sarmento B, Martins C. In vitro models of the interplay between glioblastoma and blood-brain barrier for stratifying drug efficacy. Adv Drug Deliv Rev 2025;227:115702. doi: 10.1016\/j.addr.2025.115702","DOI":"10.1016\/j.addr.2025.115702"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_030","doi-asserted-by":"crossref","unstructured":"Juri\u010d A, Zandona A, Lovakovi\u0107 BT, Ra\u0161i\u0107 D, Pizent A, Kozina G, Katalini\u0107 M, Vrdoljak AL, Kara\u010donji IB. Cytotoxic, genotoxic, and oxidative stress-related effects of lysergic acid diethylamide (LSD) and phencyclidine (PCP) in the human neuroblastoma SH-SY5Y cell line. Arh Hig Rada Toksikol 2021;72:333\u201342. doi: 10.2478\/aiht-2021-72-3604","DOI":"10.2478\/aiht-2021-72-3604"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_031","doi-asserted-by":"crossref","unstructured":"Topalovi\u0107 D, \u017divkovi\u0107 L, Borozan S, Santibanez JF, Spremo-Potparevi\u0107 B. An in vitro evaluation of the cytotoxic potential of medicinal mushrooms against human breast cancer cell lines. Arh Hig Rada Toksikol 2024;75:297\u2013302. doi: 10.2478\/aiht-2024-75-3915","DOI":"10.2478\/aiht-2024-75-3915"},{"key":"2026070319573366245_j_aiht-2026-77-4098_ref_032","doi-asserted-by":"crossref","unstructured":"Zandona A, Marceli\u0107 L, \u017dunec S, Maduni\u0107 J, Katalini\u0107 M. Effects of N-alkyl quaternary quinuclidines on oxidative stress biomarkers in SH-SY5Y cells. Arh Hig Rada Toksikol 2025;76:203\u201310. doi: 10.2478\/aiht-2025-76-4007","DOI":"10.2478\/aiht-2025-76-4007"}],"container-title":["Archives of Industrial Hygiene and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/aiht-2026-77-4098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:59:55Z","timestamp":1783108795000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/aiht-2026-77-4098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,30]]},"published-print":{"date-parts":[[2026,6,1]]}},"alternative-id":["10.2478\/aiht-2026-77-4098"],"URL":"https:\/\/doi.org\/10.2478\/aiht-2026-77-4098","relation":{},"ISSN":["1848-6312"],"issn-type":[{"value":"1848-6312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}